MUCOLYTICS FOR CHILDREN: DIFFICULT ISSUES, KEY SOLUTIONS
https://doi.org/10.15690/vsp.v13i1.909
Abstract
The author analyzed the most common questions of mucolytic agents selection asked by clinicians. The various clinical effects of N-acetyl cysteine and indications for different forms of this drug, especially in infants, are discussed in the article. Indications and contraindications of acetyl cysteine usage for treatment of dry and productive cough in combination with other medicines in the first 24 hours of acute respiratory tract infections, accompanied by adherent bronchial discharge, are listed. The causes of the pulmonary
«swamping» and measures of prevention of this condition are shown.
«swamping» and measures of prevention of this condition are shown.
About the Author
O. I. Simonova
Scientific Centre of Children Health, Moscow
I.M. Sechenov First Moscow Medical State University
Russian Federation
Russian Federation
References
1. Simonova O.I. Vopr. sovr. pediatrii = Current pediatrics. 2013; 12 (4): 136–141.
2. Soroka N.D. Vopr. sovr. pediatrii = Current pediatrics. 2008; 7 (4): 111–114.
3. Den'gin V.V. Farmateka = Pharmateca. 2008; 4: 48–52.
4. Zaitseva O.V. RMZh = Russian medical journal. 2009; 19: 1217–1222.
5. Maev I.V., Busarova G.A. Lechashchii vrach = Practicing doctor. 2003; 1: 41–47.
6. Mukoaktivnaya terapiya. Pod red. A.G. Chuchalina, A.S. Belevskogo [Mukoactive Therapy. Edited by A.G. Chuchalin, A.S. Belevskii]. Moscow, Atmosfera, 2006. 127 p.
7. Kapranov N.I., Kashirskaya N.Yu. et al. Mukovistsidoz. Sovremennye dostizheniya i aktual'nye problemy. Metod. rekomendats. 4-e izd., pererab. i dop [Cystic Fibrosis. Modern Achievements and Current Problems. Method. Recommendations. 4th ed., revised and enlarged]. Moscow, Mediko-geneticheskii nauchnyi tsentr RAMN, 2011. 92 p.
8. Volkov I.K. Diagnosticheskaya i terapevticheskaya effektivnost' bronkhoskopii pri khronicheskikh i retsidiviruyushchikh bronkholegochnykh zabolevaniyakh u detei: Avtoref. dis. ... dokt. med. nauk [Diagnostic and Therapeutic Efficacy of Bronchoscopy for Chronic and Recurrent Bronchopulmonary Diseases in Children. Author’s abstract]. Moscow, 1993.
9. Klyachkina I.L. Consilium medicum = Consilium medicum. 2008; 10 (3): 124–128.
10. Samuni Y., Goldstein S., Dean О., Berk М. The chemistry and biological activities of N-acetylcysteine. Biochimica et Biophysica Acta. 2013; 1830: 4117–4129.
11. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Copyright © 2013 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd.
12. Lokshina E.E., Zaitseva S.V., Zaitseva O.V. Vopr. prakt. pediatrii = Problems of practical pediatrics. 2011; 6 (1): 67–72.
13. Namazova-Baranova L.S., Davydova I.V. RMZh = Russian medical journal. 2013; 25: 1233–1236.
14. Besedina M.V. Praktika pediatra = Pediatrician experience. 2007; 5: 64–66.
15. Simonova O.I. Vrach = The doctor. 2010; 2: 56–61.
16. Davis S.S., Deverell L.C. Rheological factors in mucociliary clearance: the assessment of mucotropic agents using in vitro model. Mod. Prob. Paediatric. 1977; 19: 207–232.
17. Kupczyk M., Kuna P. Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties. Pol. Merkuriusz. Lek. 2002; 12 (69): 248–252.
18. Macchi A., Ardito F., Marchese A. et al. Efficacy of N-acetylcisteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even if sustained by bacterial biofilms. J. Chemother. 2006; 18: 507–513.
19. Roveta A., Debbia E., Schito G., Marchese A. Comparison of the activity of N-acetylctsteine, ambroxol, bromexine and sobrerol on Staphylococcus aureus biofilms. GIMMOC. 2004; 8: 1–12.
20. Bellomo G., Giudice S. Controlled study on the efficacy of a combination «thiamphenicol-acetylcysteine» in oral administration in respiratory infections in pediatrics. Clin. Pediatrics. 1972; 54: 30–51.
Review
For citations:
Simonova O.I. MUCOLYTICS FOR CHILDREN: DIFFICULT ISSUES, KEY SOLUTIONS. Current Pediatrics. 2014;13(1):26-32. (In Russ.) https://doi.org/10.15690/vsp.v13i1.909
Views:
1220
Email this article 
